The Heart Healthy Tocotrienol Complex Tocomin SupraBio

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "The Heart Healthy Tocotrienol Complex Tocomin SupraBio"

Transcription

1 The Heart Healthy Tocotrienol Complex Tocomin SupraBio

2 The Heart Healthy Tocotrienol Complex Tocomin SupraBio

3

4

5

6

7 1. Fact Sheet No. 317; World Health Organization (WHO), LLOYD-JONES D. et al. Circulation 2009, 119, e1-e Summary Health Statistics for U.S. Adults: National Health Interview Survey, 2007; Vital and Health Statistics, Series 10, No.240; Centers for Disease Control and Prevention (CDC), 2009, 169 pages; ALLENDER S. et al. European Cardiovascular Disease Statistics, 2008 Edition; European Heart Network 6. HO D et al. US Patent 7,544, MARCHIOLI R. et al. Lancet 1999, 354, LONN E. et al. JAMA 2005, 293, LEE I.M. et al. JAMA, 2005, 294, SESSO H.D. et al. JAMA 2008, 300, BURTON G.W. et al. Am. J. Clin. Nut. 1998, 67 (4), HANDELMAN G.J. et al. J. of Nutrition 1985, 115 (6), SERBINOVA E. et al. Free Radic. Biol. Med. 1991, 10 (5), DAS S. et al. Am. J. Physiol. Heart Circ. Physiol, 2008, 294, H KOOYENGA D.K. et al. Asia Pacific J. Clin. Nutr. 1997, 6 (1), WANG Q. et al. Biochem. Biophys. Res. Commun. 1998, 246 (3), THERIAULT A. et al. Arteriosclerosis Thrombotic Vascular Biology 1999, 19, QURESHI A.A. et al. Am. J. Clin. Nutr. 1991, 53 (Suppl 4), 1021S-1026S 19. QURESHI A.A. et al. Lipids 1995, 30 (12), THERIAULT A. et al. American Association for Clinical Chemistry (AACC) National Meeting 2000, Jul 23-27, San Francisco 21. CHATELAIN E. et al. Biochim Biophys Acta - Molecular Cell Research 1993, 1176 (1-2), GOLDSTEIN J.L., BROWN M.S.. Nature 1990, 343, CORRELL C.C. et al. J. Biol. Chem , QURESHI A.A. et al. Nutr. Biochem. 1997, 8, QURESHI A.A., PETERSON D.M. Atherosclerosis 2001, 156 (1), QURESHI A.A. et al. J. Nutr. 1996, 126 (2), NEWAZ M.A., Nawal N.N. Clin. Exp. Hypertens. 1999, 21 (8), RASOOL A.H.G. et al. J. Nutr. Sci. Vitaminol. 2006, 5 (6), RASOOL A.H.G. et al. Arch. Pharm. Res. 2008, 31 (9), LAURENT S. et al. Hypertension 2001, 37, WILLUM-HANSEN T. et al. Circulation 2006, 113 (5), YAP S.P. et al. J. Pharm. Pharmacol. 2001, 53 (1), HO D. et al. US Patent Sharon Ling. TocominSupraBio - The heart healthy tocotrienol complex. NutraCos November/December 2009;

8

437“ƒ

437“ƒ et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer

More information

VOL33NO.3/2010 A B A B p-erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 Erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 p-vasp VASP C D enos/gapdh x-fold vs sham 2.0 1.5 1.0 0.5 * 0 ANP (-) (+) (-)

More information

日本皮膚科学会雑誌第122巻第2号

日本皮膚科学会雑誌第122巻第2号 J Dermatol Sci Vitam Horm NEnglJMed Lancet J Clin Invest Antitoxid Redox Signal Diabetes Metab Res Rev Diabetes Care Diabet Med Diabetes care Diabetes Care J Foot Ankle Surg Wound Repair Regen Lancet Foot

More information

Novel chemical mediators in the resolution of inflammation Charles N. Serhan Key words E-mail : marita@nih.go.jp Charles N. Serhan Brigham & Women's Hospital/Harvard Medical School 1) Serhan, C. N.,

More information

Bio-No.57/3....

Bio-No.57/3.... 2004. MAR. 3No.57 http://www.wako-chem.co.jp C O N T E N T S 2 Wako Bio Window No.57 MAR.2004 l l l l wako wako l l mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm Wako Bio Window No.57 MAR.2004 3 4 Wako Bio Window

More information

1) van Meer, G., Op den Kamp, J. A.: J. Cell. Biochem., 19, 193-2040982) 2) Gaffet, P., Bettache, N., Bienvenue, A.: Biochemistry, 34, 6762-6769(1995) 3) Sims, P. J., Wiedmer, T.: Thromb. Haemost., 86,

More information

Contents 1 4 Section Column Section

Contents 1 4 Section Column Section Contents 1 4 Section1 7 8 16 23 34 40 Column Section2 47 48 58 64 70 Section3 75 76 82 88 Interview Interview 94 96 Prologue Prologue Section 1 1 8 9 Section 1 10 1 19.8 19.1 17.4 14.6 16.0 16.9 48.7

More information

Complex sleep apnea syndrome and sleep disordered breathing in patients with cardiovascular disease V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) Sleep J Clin

More information

表1.eps

表1.eps Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol

More information

2007050781......_.L.O...z.W

2007050781......_.L.O...z.W a s d f g a s d f g h j k l 0 in vitro in vivo in vitro in vivo in vivo in vivo in vitro Metabolism Metabolism Endocr Endocr Endocrinol Ann NYA cad Sci J clin Endocr Metab

More information

フィナレビ106号.indb

フィナレビ106号.indb 2009 3 30 2009 4 14 CDC 2009 4 25 WHO 2009 4 26 2009 4 28 2009 4 28 2009 4 30 2009 5 1 2009 5 8 6 2009 5 9 2009 5 23 2009 6 3 2009 6 9 2500 2009 6 12 WHO 6 2009 6 28 2009 8 9 1 1 2009 8 15 2009 8 19 2010

More information

生物

生物 Biology 115-470 115-419 60 SERIES 114-171 114-170 114-172 114-029 114-138 61 114-372 114-370 62 Biology K22486-000 K22435-000 K22486-010 144-300 K22467-000 63 64 144-200 244-115 248-150 144-190 144-195

More information

Various function and toxicity of iron Key words 1) Hentze, M. W. et al: Cell, 117, 285-297 (2004) 2) Ganz, T.: Blood, 102, 783-788 (2003) 3) Nemeth, E. et al.: Science, 306, 2090-2093 (2004) 4) Hentze,

More information

2001 2003 2005 2006 2007 2008

2001 2003 2005 2006 2007 2008 2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65

More information

tary adenylate cyclase activating polypeptide ; PA-

tary adenylate cyclase activating polypeptide ; PA- Conformation of a peptide ligand bound to its G-protein coupled receptor and its implication for ligand transportation tary adenylate cyclase activating polypeptide ; PA- molecular biology (ed. Rich,

More information

日本皮膚科学会雑誌第122巻第7号

日本皮膚科学会雑誌第122巻第7号 Br J Dermatol NEnglJ Med 尋常性白斑診療ガイドライン 図 1 先天性白斑 白皮症の病型分類 図 2 後天性白斑 白皮症の病型分類 の尋常性白斑患者で家系内発症がみられることより 3 5 れらの合併が染色体 17p13 における一塩基多型に起 非分節 因し その候補遺伝子の一つが自然免疫に重要とされ 型に含まれる汎発型には甲状腺に対する抗サイログロ る NALP1 遺伝子であると報告している6

More information

3) Z. Nambu: in preparation (1971). 4) N. P. Wilkins & J. D. Iles: Comp. Biochem. Physiol., 17, 1141 (1966). 5) V. M. Ingram: Nature, 235, 338 (1972). Bacillus cereus var. mycoides, Bacillus thuringiensis

More information

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Journal Physiology, American Journal of Physiology, Journal of Physiology, Journal of Autonomic Nervous System, American Journal of Physiology,

More information

日本皮膚科学会雑誌第121巻第11号

日本皮膚科学会雑誌第121巻第11号 β Clin Rheumatol Arthritis Rheum Am J Cardiol J Rheumatol J Rheumatol Arthritis Rheum Arthritis Rheum Arthritis Rheum Rheumatology Oxford Rheumatology Oxford Br J Dermatol Arch Dermatol Ann Rheum Dis

More information

medicaljournal8.pdf

medicaljournal8.pdf Medical Journal of Aizawa Hospital Vol. 8 (2010) Key words Neuropsychopharmacology Neuroscientist Curr Opin Neurol Clin Rehabil J Neurol Neurosurg Psychiatry J Neurol Neurosurg Psychiatry Lancet

More information

2009 Aida et al. Caries Res 2006;40 2000 100 % 78.7 88.0 96.6 98.8 98.8 98.8 100.0 100.0 100 75 69.4 50 75.3 74.8 73.3 73.1 73.0 72.4 71.8 71.7 51.7 40.2 69.4 68.8 73.6 25 22.3 32.8 21.9 22.9 22.1

More information

4) H. Takayama et al.: J. Med. Chem., 45, 1949 (2002). 5) H. Takayama et al.: J. Am. Chem. Soc., 112, 8635 (2000). 6) H. Takayama et al.: Tetrahedron Lett., 42, 2995 (2001). 9) M. Kitajima et al: Chem.

More information

2 21 211,,, (Hz), AM (1MHz), 300m, 24 (245GHz), 12cm, 212 (electromagnetic fields), (electromagnetic radiations) (NIR),X,,,, RF, ELF,,, 22 221,, 2005

2 21 211,,, (Hz), AM (1MHz), 300m, 24 (245GHz), 12cm, 212 (electromagnetic fields), (electromagnetic radiations) (NIR),X,,,, RF, ELF,,, 22 221,, 2005 1 2003 6 7500 2 1 1 1 WHO, IARC, 2004 2 1973 1993 16 1997 SAR 2002 6, SAR 2W/kg, WHO ICNIRP 2 21 211,,, (Hz), AM (1MHz), 300m, 24 (245GHz), 12cm, 212 (electromagnetic fields), (electromagnetic radiations)

More information

untitled

untitled 2005 10 13 Dr. RGA 19602000 10 Australian Institute of of Health and and Welfare 2004 ABS Cat. Cat. No. No. 3201.0; AIHW National Population Database 1875 2 211997 8 122164 http://www.wowzone.com/calment.htm

More information

Medical Journal of Aizawa Hospital Medical Journal of Aizawa Hospital Vol. 8 (2010) Key words Neuropsychopharmacology Neuroscientist Curr Opin Neurol Clin Rehabil J Neurol Neurosurg Psychiatry

More information

加藤茂孝先生

加藤茂孝先生 ooooooo oooooooooooooooooooooooooo 10 30 11 oooooooooooooooooooooooooo Shigetaka KATOW ooooooo 1 1 1 100 1 1 3 2003 SARS SARS 9.11 2 2 30 2003 SARS 2009 200 SARS 1 2001 0101-0051 - RIKEN Center of Research

More information

untitled

untitled 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Int J Radiat Oncol Biol Phys 49 Cancer 101 Int J Radiat Oncol Biol Phys 60 Chest 124 Int J Radiat Oncol Biol Phys 56 Int J Radiat Oncol Biol Phys 49 Chest 124 Int J

More information

2007 Vol.56 No.6 総説 丸山浩樹

2007 Vol.56 No.6 総説 丸山浩樹 Reprinted from RADIOISOTOPES, Vol.56,.6 June 2007 Japan Radioisotope Association http : //www.jrias.or.jp/ α β α β ε m z α µ µ α m z m z µ µ Curr. Opin. Biotechnol J. Proteome Res Rapid Commun. Mass

More information

理学療法科学シリーズ臨床運動学第6版サンプル

理学療法科学シリーズ臨床運動学第6版サンプル μ μ μ μ μ α μ 1) Appell HJ: Skeletal muscle atrophy during immobilization. Int J Sports Med 7: 1-5, 1986. 2) Bohannon RW: Make tests and break tests of elbow flexor muscle strength.

More information

MNT MNT CVD MNT 1) 2) 3) 4) MNT 1) 1 2 2) MNT MNT MNT MNT 1 1 2 1 % HbA1C 2

MNT MNT CVD MNT 1) 2) 3) 4) MNT 1) 1 2 2) MNT MNT MNT MNT 1 1 2 1 % HbA1C 2 2008 American Diabetes Association, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008 Jan; 31 Suppl 1: S61-S78.

More information

H1.eps

H1.eps Contents 1 4 Section 1 7 1 2 3 8 14 21 Section 2 27 1 2 3 28 34 40 Section 3 43 1 2 3 44 49 57 Section 4 63 1 2 3 4 5 64 72 77 84 88 96 Prologue Prologue S e c t i o n 1 1 8 S e c t i o n1 9 1 10 S e

More information

2016.05月号cs5.indd

2016.05月号cs5.indd 5 2016.5.1 2 3 2016.5.1 2016.5.1 4 5 2016.5.1 2016.5.1 6 2016.5.1 7 2016.5.1 8 2016.5.1 9 2016.5.1 10 11 2016.5.1 2016.5.1 12 2016.5.1 13 Healthy 2016.5.1 14 2016.5.1 15 Healthy 2016.5.1 16 2016.5.1 17

More information

untitled

untitled Fig.1 t O O N,N p n J J J J J t J J J J J J J J J J J t t J J J J J J J J J p Fig.2 p t Fig.3 Fig.4 synanti p Table1 Table2t Table2 synanti antisyn synanti synanti Fig.5 syn anti anti Fig.6 Table3 Table4

More information

2012 Vol.61 No.5 p.388 398 The National Health and Nutrition Survey in the promotion and evaluation of health policies: Its role and history as a long-term health-monitoring tool Nobuo YOSHIIKE Kimiko

More information

Establishment and progress of Sendai virus engineering 2) Schnell, M. J., Mebatsion, T., Conzelmann, K.-K.: EMBO J., 13,4195-4203(1994) 3) Kato, A. et al.: Genes Cells, 1, 569-579 (1996) 4) Nagai,

More information

Biology of spermatogenesis and spermatozoa in mammals. Biophys. Biochem. Cytol. Arch. Biochem. Biophys. Anat. Rec. Biol. Reprod. Mol. Hum. Reprod. Biol. Reprod. Reprod. Biol. Endocrinol. Aust. J. Zool.

More information

本文.indd

本文.indd CQ ACC/AHA PECO PatientExposure Comparison OutcomePECO low-density lipoprotein cholesterol LDL C cholesterol cholesterol intensive OR agressive CQ target LDL C PubMed Systematic Reviews Clinical Study

More information

10中西_他.indd

10中西_他.indd Streptomyces mobaraensis N N N Sm b Sm N N Sm Sm Sm ' ' Sm Sm ak K k K bk k K Sm Sm a b S. mobaraensis a b a b Sm b b bb b b Sm Sm S. lividans ab Sm ab Sm ab ab ab ab SmSm S. lividansab S. lividans ab

More information

2007 Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases Japan Atherosclerosis Society 1 2 3 1. 2. 3. 4. 5. 6. 7. 8. 9. 1. 5 6 7 Chapter 1 8 Chapter

More information

2 1 1 http://www.jpo.go.jp/indexj.htm International Patent Classification European Patent Classification JST Online Information System Derwent World Patent Index The Scientific and Technical Information

More information

Educational Technology Research ä Kyng Alisaunder Havelok the Dane Kyng Alisaunder ELT Journal La

More information

Q-...g.L..465

Q-...g.L..465 20 8 H e a r t F u l l I n f o r m a t i o n No.465 2 Heart Full Information 3 3 27 6 0 22 3 Heart Full Information 29 42 79 50 29 20 30 5 9 5 5 22 96 86 22 4 Heart Full Information 53 24 5 Heart Full

More information

2

2 u u u u u u u u u u u 2 s s s 3 s s s s 4 e 5 s s ss s s s s s s s u aa eaa u u u e u 6 7 8 u u 9 u u 0 A A 2 2 3 t 6 t t t t A 2 3 d d d d A A 4 5 444444444444444444444444444 4444444444444444444444444444444444

More information

38-5 History/柴

38-5 History/柴 V o l. 3 8 N o. 5 ( 2 0 0 6 ) V o l. 3 8 N o. 5 ( 2 0 0 6 ) V o l. 3 8 N o. 5 ( 2 0 0 6 ) V o l. 3 8 N o. 5 ( 2 0 0 6 ) V o l. 3 8 N o. 5 ( 2 0 0 6 ) Jpn Heart J Acta Med Scand Z Kreislaufforsch Jpn

More information

第6号-2/8)最前線(大矢)

第6号-2/8)最前線(大矢) 最前線 免疫疾患における創薬標的としてのカリウムチャネル 大矢 進 Susumu OHYA 京都薬科大学薬理学分野教授 異なる経路を辿る 1つは マイトジェンシグナル 1 はじめに を活性化し 細胞増殖が促進されるシグナル伝達経 路 図1A 右 であり もう1つはカスパーゼやエ 神 経 筋 の よ う な 興 奮 性 細 胞 で は カ リ ウ ム ンドヌクレアーゼ活性を上昇させ アポトーシスが K

More information

CRPNo30表紙.ai

CRPNo30表紙.ai No.30 2012/6 20126 Clinical Research Professionals No.30 17 18 Clinical Research Professionals No.30 2012 6 20126 Clinical Research Professionals No.30 19 20 Clinical Research Professionals No.30 2012

More information

[Department of Pediatrics, Gifu University School Clinical. Pathological and Biochemical Abnormality in peroxisomal Disorders 1) Goldfischer, S., Moore, C. L., Johnson, A. B., Spiro, A. J., Valsamis,

More information

1950 1970 1990 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 6,788 7,123 5,384 4,915 4,908 4,927 4,895 4,919 4,936 4,927 4,897 5,010 5,008 1,456 1

1950 1970 1990 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 6,788 7,123 5,384 4,915 4,908 4,927 4,895 4,919 4,936 4,927 4,897 5,010 5,008 1,456 1 1950 1970 1990 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 6,788 7,123 5,384 4,915 4,908 4,927 4,895 4,919 4,936 4,927 4,897 5,010 5,008 1,456 1,616 927 824 826 821 813 808 802 803 801 808 806 18,483

More information

2.2 Gompertz-Makeham Gompertz Makeham Gompertz Gavrilov and Gavrilova Gavrilov and Gavrilova (1991) Mori and Nakazawa (2003) S 2.3 40 80 DNA mev-1 II

2.2 Gompertz-Makeham Gompertz Makeham Gompertz Gavrilov and Gavrilova Gavrilov and Gavrilova (1991) Mori and Nakazawa (2003) S 2.3 40 80 DNA mev-1 II (1) 2011 6 20 (nminato@med.gunma-u.ac.jp) 1 aged population senior citizen elderly people 65 65 65 65 65-74 75 1. 2. 3. 13 2001 12 28 *1 65 2 2.1 (1) (2) (3) (4) *1 http://www8.cao.go.jp/kourei/measure/taikou/index-t.html

More information

審査報告書(案)

審査報告書(案) 19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET

More information

化学療法剤の適切な使い方について

化学療法剤の適切な使い方について 1 2 3 4 5 6 7 Che E, in Cancer: Principles & Practice of Oncology (7th ed) in Devita, 2005 Marangolo M, Oncol Rep, 2006 hryniuk WM, Important Adv Oncol, 1988 8 Cancer: Principles & Practice of Oncology

More information

5200) [Department of Biochemistry, Miyazaki Medical College, Kihara, Kiyotake-cho, Miyazaki 889-16, Japan] Natriuretic Peptide Family: ANP and BNP 1) de Bold, A. J.: Science, 230, 767-770 (1985)

More information

香港

香港 FTA CEPA 1970 1980 1980 51 1999 1998 24 2000 2007 2006 11 52 1999 FTA FTA FTA 2001 11 WTO WTO FTA FTA 53 FTA CEPA FTA WTO FTA CEPA 2000 FTA FTA 2000 17 FTA 2000 11 WTO 2000 FTA WTO FTA FTA FTA FTA 2001

More information

電子ジャーナルに関する アンケート調査 集計結果

電子ジャーナルに関する アンケート調査 集計結果 電 子 ジャーナルに 関 する アンケート 調 査 集 計 結 果 東 海 大 学 付 属 図 書 館 伊 勢 原 図 書 館 2012.1 電 子 ジャーナルに 関 する アンケート 調 査 結 果 報 告 2011 年 11 月 10 日 ~30 日 に 実 施 いたしました 電 子 ジャ ーナルに 関 するアンケート 調 査 につきましては ご 多 忙 中 にも 関 わらずご 協 力 を 賜

More information

NEWS LETTER No.10 (Page 1)

NEWS LETTER No.10 (Page 1) Who When Where What Why How Who When Where What Why How U.S. Department of Agriculture / U.S. Department of Health and Human Services Guide Line PEOPLE'S REPUBLIC OF CHINA GUIDE LINE NORWAY WHO WHEN WHERE

More information

3 4 6 7 8 9 10 12 14 2 3

3 4 6 7 8 9 10 12 14 2 3 3 4 6 7 8 9 10 12 14 2 3 POINT 4 5 3053 1323 4 7 6 1 1 4 7 Yamada N. et al : Int J Cardiol. 98, 409-411, 2005 6 7 POINT 0 20 40 60 80 100 60 80 Ota M. et al: Heart Vessels. 17, 7-11,2002 40 60 20 50 15

More information

BMI18 1

BMI18 1 The role of nutrition intervention for increasing body weight in college girls with BMI less than 18. Yukiko Miyake BMI18 1 BMI18 1950 2 1/10 2007 1 14 NY DSMIV WHO ICD101992 2 17 20 BMI18.5 22.6 21 21

More information

; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9

; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9 32, 21-25, 2012 CASLE 1 1 80 26 6 5 4 cm 1 2 CEA 3 4 CEA 2 44 22 2 3 1.5 cm 22 1. 1 ; 6 5 4 cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml 0-40 5 Mφ 6 7, 8 9 23 6. ; 9. ; 7. ; 10. ; 8. 7 10 CK3 CK3 24 1,2 3 2 8% 4,5

More information

日本皮膚科学会雑誌第121巻第14号

日本皮膚科学会雑誌第121巻第14号 World J Surg Burns Burns JTrauma Lancet Lancet Surg Gynecol Obste J Burn Care Rehabil BMJ Pediatr Emerg Care The Treatment of Burns Burns, A Team Approach Surg Gynecol Obstet NEnglJMed J Burn Care Rehabil

More information

2 はじめに 健康食品をめぐる問題点 a) 有効性に関する問題点 4 HPLC HPLC 3 CoQ10

2 はじめに 健康食品をめぐる問題点 a) 有効性に関する問題点 4 HPLC HPLC 3 CoQ10 1 総 説 健康食品をめぐる問題と展望 長村 洋一 キーワード : DSHEA 要旨 6 2 はじめに 6 26 1 8 20 1 2 3 1. 健康食品をめぐる問題点 a) 有効性に関する問題点 4 HPLC HPLC 3 CoQ10 3 図 1 市販されている健康食品の含有量の実態 ( 国民生活センターのホームページより ) b) 安全性に関する問題点 17 18 4 18 4 5 - - -

More information

O-1 O-2 O-3 O-4 O-5 O-6

O-1 O-2 O-3 O-4 O-5 O-6 18 The 18 th Congress of Hokkaido Association for Clinical Engineering Technologists 930940 O-1 O-2 O-3 O-4 O-5 O-6 O-7 O-8 O-9 O-10 O-11 O-12 O-13 O-14 O-15 O-16 O-17 O-18 O-19 O-20 O-21 O-22 O-23 O-24

More information

2007 Vol.56 No.10 総説 中田浩二

2007 Vol.56 No.10 総説 中田浩二 Reprinted from RADIOISOTOPES, Vol.56,.10 October 2007 Japan Radioisotope Association http : //www.jrias.or.jp/ Gastroenterology Gastroenterology Gastroenterology J. Smooth Muscle Res Gastroenterology

More information

31 33

31 33 17 3 31 33 36 38 42 45 47 50 52 54 57 60 74 80 82 88 89 92 98 101 104 106 94 1 252 37 1 2 2 1 252 38 1 15 3 16 6 24 17 2 10 252 29 15 21 20 15 4 15 467,555 14 11 25 15 1 6 15 5 ( ) 41 2 634 640 1 5 252

More information

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents D 012 Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents DATA : 1 DATA : 2 3 DATA : UNGITEC 1 1 DATA : 20pg/mL 1020pg/mL 10pg/mL (cut off 20pg/mL) 90.2%(37/41) 100%(85/85) 96.8%(122/126)

More information

橡matufw

橡matufw 3 10 25 3 18 42 1 2 6 2001 8 22 3 03 36 3 4 A 2002 2001 1 1 2014 28 26 5 9 1990 2000 2000 12 2000 12 12 12 1999 88 5 2014 60 57 1996 30 25 205 0 4 120 1,5 A 1995 3 1990 30 6 2000 2004 2000 6 7 2001 5 2002

More information